Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Massachusetts General Hospital
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
AHS Cancer Control Alberta
Pfizer
Grupo Español de Investigación en Neurooncología
University Hospital Heidelberg
Sun Yat-sen University
Emory University
Pediatric Brain Tumor Consortium
University of California, San Francisco